EZH2 Is Essential for Fate Determination in the Mammalian Isthmic Area

被引:6
|
作者
Wever, Iris [1 ]
Wagemans, Cindy M. R. J. [1 ]
Smidt, Marten P. [1 ]
机构
[1] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands
来源
关键词
Ezh2; mid-hindbrain border; dopamine; seretonin; epigenetics; MIDBRAIN DOPAMINERGIC-NEURONS; SUBSTANTIA-NIGRA; HISTONE METHYLTRANSFERASE; DEVELOPMENTAL REGULATORS; POLYCOMB COMPLEXES; DNA METHYLATION; WNT1; EXPRESSION; FLOOR PLATE; CELLS; FGF8;
D O I
10.3389/fnmol.2019.00076
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The polycomb group proteins (PcGs) are a group of epigenetic factors associated with gene silencing. They are found in several families of multiprotein complexes, including polycomb repressive complex 2 (PRC2). EZH2, EED and SUZ12 form the core components of the PRC2 complex, which is responsible for the mono, di- and trimethylation of lysine 27 of histone 3 (H3K27Me3), the chromatin mark associated with gene silencing. Loss-of-function studies of Ezh2, the catalytic subunit of PRC2, have shown that PRC2 plays a role in regulating developmental transitions of neuronal progenitor cells (NPCs); from self-renewal to differentiation and the neurogenic-to-gliogenic fate switch. To further address the function of EZH2 and H3K27me3 during neuronal development, we generated a conditional mutant in which Ezh2 was removed in the mammalian isthmic (mid-hindbrain) region from E10.5 onward. Loss of Ezh2 changed the molecular coding of the anterior ventral hindbrain leading to a fate switch and the appearance of ectopic dopaminergic (DA) neurons. The correct specification of the isthmic region is dependent on the signaling factors produced by the Isthmic organizer (IsO), located at the border of the mid- and hindbrain. We propose that the change of cellular fate is a result of the presence of Otx2 in the hindbrain of Ezh2 conditional knock-outs (cKOs) and a dysfunctional IsO, as represented by the loss of Fgf8 and Wnt1. Our work implies that next to controlling developmental transitions, EZH2 mediated gene silencing is important for specification of the isthmic region by influencing IsO functioning and repressing Otx2 in the hindbrain.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] The role of EZH2 in tumour progression
    C-J Chang
    M-C Hung
    British Journal of Cancer, 2012, 106 : 243 - 247
  • [42] Targeting EZH2 in cancer therapy
    Yamagishi, Makoto
    Uchimaru, Kaoru
    CURRENT OPINION IN ONCOLOGY, 2017, 29 (05) : 375 - 381
  • [43] EZH2 in B lymphocyte commitment
    Jacobsen, Jennifer
    Kee, Barbara
    JOURNAL OF IMMUNOLOGY, 2015, 194
  • [44] EZH2 as a therapeutic target for glioma
    Faruck, Lukmanul Hakkim
    Day, Charles
    Bhattarai, Suraj
    Langfald, Alyssa
    Hinchcliffe, Edward
    Robinson, James
    CANCER RESEARCH, 2024, 84 (05)
  • [45] EZH2 inhibitors in immunotherapy of melanoma
    Hersey, Peter
    Gallagher, Stuart
    Tiffen, Jessamy
    Shklovskaya, Elena
    Wilson, Stephen
    Filipp, Fabian
    CANCER RESEARCH, 2017, 77
  • [46] EZH2 in normal and malignant hematopoiesis
    K Lund
    P D Adams
    M Copland
    Leukemia, 2014, 28 : 44 - 49
  • [47] Review: Targeting EZH2 in neuroblastoma
    Gao, Jinhui
    Fosbrook, Claire
    Gibson, Jane
    Underwood, Timothy J.
    Gray, Juliet C.
    Walters, Zoe S.
    CANCER TREATMENT REVIEWS, 2023, 119
  • [48] Role of EZH2 in Ovarian Carcinogenesis
    Bandyopadhyay, S.
    Sood, A.
    Munkarah, A. R.
    Arabi, M. H.
    Guan, H.
    Hayek, K.
    Ali-Fehmi, R.
    MODERN PATHOLOGY, 2009, 22 : 207A - 207A
  • [49] EZH2 Inhibitors: The Unpacking Revolution
    Adema, Vera
    Colla, Simona
    CANCER RESEARCH, 2022, 82 (03) : 359 - 361
  • [50] Regulation and Role of EZH2 in Cancer
    Yamaguchi, Hirohito
    Hung, Mien-Chie
    CANCER RESEARCH AND TREATMENT, 2014, 46 (03): : 209 - 222